Dr Aleksandra Gentry-Maharaj

Research summary

Main interest in ovarian and endometrial cancer screening. Alex is the Project Lead for the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), a randomised controlled trial involving 202,638 women from the UK assessing the mortality impact of screening. She has contributed to over 80 publications resulting from the trial, both from the core trial and all secondary studies. Since 2005, Alex has contributed to the International Ovarian Cancer Association Consortium (OCAC) looking at genetic predisposition to ovarian cancer and has contributed to over 100 publications in this field, including the first GWAS. 

Alex has contributed to the area of biomarker discovery in ovarian cancer and led the papers exploring the value of HE4 in both screening and differential diagnosis. She has authored 5 chapters focussing on ovarian cancer biomarkers in the main gynaecological oncology textbooks and 5 reviews of ovarian cancer screening.  

Alex has an interest in the menopause transition and the therapies that women use to alleviate their menopausal symptoms. Other interests include biomarker discovery for other cancers and cardiovascular disease.

Since 2020, expanded work trials in adjuvant setting in a role if Project Co-lead for Add-Aspirin and ICON8B. 

Since 2022, CRUK ACED Co-Director of Research Domain Trials.

Teaching summary

MSc Clinical Trials Programme Director

Co-lead for the following modules:

* Applying Clinical Trial Design Principles in Practice module on the MSc Clinical Trials 

* Women's Cancers module on the iBSc Women's Heath 

* Concept and Controversies of Women's Health module on the MSc Women's Health 

* Breast and Reproductive Cancers on the MSc Reproductive Science and Women's Health 

Education Webinar Lead for the International HundredK+ Cohorts Consortium (IHCC)